Clinical Trial Update: A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ocrelizumab vs placebo in active rheumatoid arthritis patients on methotrexate; study terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2020-11-27